Latest Medtronic Inc (MDT) Headlines Final Glan
Post# of 99
Posted On: 03/14/2014 2:29:32 AM
Latest Medtronic Inc (MDT) Headlines
Final Glance: Medical Devices companies
AP - Thu Mar 13, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
Midday Glance: Medical Devices companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Early Glance: Medical Devices companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare
PR Newswire - Thu Mar 13, 7:00AM CDT
On Wednesday, March 12, 2014, the NASDAQ Composite ended at 4,323.33, up 0.37%, the Dow Jones Industrial Average fell 0.07% to 16,340.08, and the S&P 500 closed at 1,868.20, up 0.03%. The gains were narrow based as four out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 687.90, down 0.01%, while the same has gained 3.36% in the last one month. Investor-Edge.com has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Hologic Inc. (NASDAQ: HOLX), and ArthroCare Corporation (NASDAQ: ARTC). Free research on these four companies can be accessed at:
Concise Analysis of the International Intracranial Stents Market
M2 - Thu Mar 13, 6:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4fntp/intracranial) has announced the addition of the "Concise Analysis of the International Intracranial Stents Market" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. The report profiles 16 companies including many key and niche players such as: - Admedes Schuessler GmbH - BALT Extrusion - Cardiatis SA - Codman & Shurtleff, Inc. - Covidien PLC - ITGI Medical Ltd. - Medtronic, Inc. - MicroPort Scientific Corporation - OBEX Medical - Penumbra, Inc. - Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Issues & Challenges 3. Product Overview 4. Neurovascular Diseases - An Overview 5. Product Introductions & Approvals 6. Recent Industry Activity 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Europe 3. Rest Of World IV. Competitive Landscape Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18) - The United States (7) - Europe (6) - France (1) - Germany (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/r4...tracranial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
United States Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 5:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jjmsm9/united_states) has announced the addition of the "United States Orthobiologics Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Bone Graft Substitutes - Viscosupplementation - Bone Allografts - Bone Growth Stimulators The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. Scope - Market size for Orthobiologics market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the United States Orthobiologics market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution? Identify, understand and capitalize. Key Topics Covered - Introduction - Orthobiologics Market, United States - Overview of Key Companies in United States Orthobiologics Market - Orthobiologics Market Pipeline Products - Financial Deals Landscape - Recent Developments - Appendix Companies Mentioned - Anika Therapeutics - Baxter International - Biomet - DJO Finance - DePuy - Globus Medical - Medtronic - NuVasive - Sanofi - Seikagaku - Smith & Nephew - Stryker - Wright Medical For more information visit http://www.researchandmarkets.com/research/jj...ted_states About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
2014 Bone Grafts Global Strategic Business Report - Growing Clinical Use of Bone Graft Substitutes in Surgical Procedures
M2 - Thu Mar 13, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtgc4c/bone_grafts) has announced the addition of the "Bone Grafts - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Bone Grafts in US$ Million. The US market for Bone Graft Substitutes is also analyzed by the following segments: Standard Allografts, Machined Bone Allografts, Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Stem Cell Based Bone Grafts, and Synthetic Bone Grafts. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS 3. PRODUCT OVERVIEW 4. REGULATORY ENVIRONMENT & REIMBURSEMENTS 5. PRODUCT INNOVATIONS/INTRODUCTIONS - AlloSource Introduces AlloMend - Orthofix Launches Trinity? ELITE - Synergy Biomedical to Introduce Biosphere Putty - K2M Launches VENADO Bone Graft Systems - Bonesupport Receives CE Mark Approval for Cerament|G resorbable - PlusLife? Launches Innovative Allogeneic Bone Gel for Orthopedic Uses (Australia) - RTI Surgical Introduces BioReady DBM Putty - K2M Rolls Out VESUVIUS Osteobiologic Systems - BioHorizons Introduces MinerOss? Cancellous - Amedica Introduces Dynamic Bone - Orthogen Introduces NanoGen - SIRAKOSS Introduces MaxSi - BioMimetic to Introduce Augmatrix Biocomposite Bone Graft Line - Orthofix International Introduces Collage Osteoconductive Scaffold - BioMimetic Obtains Approval from TGA for Commercialization of Augment? Bone Graft - Medtronic Launches ARTISAN Space Maintenance System - NovaBone Introduces MacroPor-Si - RTI Surgical Announces First Application of map3TM Cellular Allogeneic Bone Graft in Ankle and Foot Fusion Procedures ( US) - Integra Receives FDA Clearance for Accell Evo3 - RTI Surgical Introduces BioAdapt DBM Foam - Integra Unveils Trel-Xpress Demineralized Bone Matrix - Keystone Dental Introduces DynaMatrix Plus - Wright Introduces FUSIONFLEX Demineralized Moldable Scaffold - Micromedics Launches OsteoXpress 15cc Bone Graft Delivery Device - Bacterin Unveils OsteoSponge?SC - Integra Launches Allograft Cancellous Sponge - Orthos Receives CE Approval for ?Gel Synthetic Bone Graft Substitute 6. RECENT INDUSTRY ACTIVITY - RTI Biologics Acquires Pioneer Surgical Technology - Wright Medical Group Acquires BioMimetic Therapeutics - Titan Spine Enters into Distribution Agreement with Biomet - Bioventus and Pfizer Enter into Agreement - AlloSource Enters into Partnership with Humacyte - MicroPort Medical to Acquire OrthoRecon Business of Wright Medical Group - J&J Takes Over Synthes - Stryker Acquires Orthovita - Zimmer Dental and Curasan Enter into Distribution Agreement - Cayenne Medical Enters into Partnership with Parametrics Medical - NuVasive Signs Licensing Agreement with AlloSource - Stryker Divests OP-1 Product Range 7. FOCUS ON SELECT PLAYERS 8. MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. EUROPE 3. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Mentioned The report profiles 61 companies including many key and niche players such as: - AlloSource - Biomet - DePuy Synthes - Synthes - DePuy Spine - Exactech - Integra LifeSciences - LifeNet Health - Medtronic - NovaBone Products - NuVasive, - Olympus Biotech - RTI Surgical - Smith & Nephew - Stryker - Wright Medical Technology - BioMimetic Therapeutics - Zimmer For more information visit http://www.researchandmarkets.com/research/dt...one_grafts About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Market Research: Mexico Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/klxv39/mexico) has announced the addition of the "Mexico Orthobiologics Market Outlook to 2020" report to their offering. "Mexico Orthobiologics Market Outlook to 2020", provides key market data on the Mexico Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Mexico Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, Mexico Overview of Key Companies in Mexico Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned Sanofi Medtronic, Inc. DePuy Companies Biomet, Inc. Orthofix International N.V. Stryker Corporation Arthrex, Inc. Wright Medical Group, Inc. DJO Finance LLC Ferring International Center S.A. Baxter International Inc. For more information visit http://www.researchandmarkets.com/research/klxv39/mexico About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019
M2 - Thu Mar 13, 3:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vzjflp/blood_and_cardiac) has announced the addition of the "Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019" report to their offering. According to the report the global blood and cardiac monitoring devices market was worth $13.6 billion in 2012 and is expected to reach $20.5 billion in 2019, growing at a CAGR of 6.0% from 2013 to 2019. The market for blood monitoring devices is segmented into blood pressure monitors, blood glucose monitors, blood gas analyzers and blood cholesterol monitors. In 2012, the market for blood glucose monitors accounted for the largest share by revenue of the total market at more than 70%. This is attributed mainly to the consistent technological up-gradations in product design followed by the alarming rise in diabetic population and sedentary lifestyles. However, the blood pressure monitors market is expected to record the highest growth during the forecast period owing to the rising prevalence and incidence rate of hypertension and increased awareness about regular monitoring of blood pressure among people. Also, due to integration of tele-medicine, patients themselves rely on self-monitoring of blood pressure at home. The market for cardiac monitoring devices has been segmented into various device types including electrocardiogram, holter monitors, event monitors, cardiac output monitors, and others (wrist rate monitors, strapped rate monitors, etc.). Of these, the market for electrocardiograms accounted for the largest share by revenue in 2012, at around 45%. Geographically, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America led the global market for both blood and cardiac monitoring devices in 2012, in terms of revenue share. With innovations in blood monitoring making the testing much less invasive for the geriatric population and other cardiac patients, revenue for the North American market is set to skyrocket. Physicians in the region are increasingly demanding to work with the newer, less invasive or noninvasive systems, which will help in rapid growth of the minimally and non-invasive blood and cardiac monitoring markets. The fastest growth in this market will be observed in the Asia-Pacific region during the forecast period. Sedentary lifestyles and the resultant rise in the prevalence of chronic illnesses, increase in the per capita income and healthcare expenditures, improvement in healthcare infrastructure and a large pool of geriatric population are the key factors fuelling market growth in the region. The market for cardiac monitors is highly oligopolistic in nature, with the top two players accounting for the majority of the market share in 2012. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics: Global Blood and Cardiac Monitoring Devices Market - Products Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Geography Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Key Players Analysis: Global Blood and Cardiac Monitoring Devices Market, 2012 (%) - Company Profiles Companies Mentioned - Dragerwerk AG & Co. - Edwards Lifesciences - GE Healthcare - ICU Medical - LiDCO - Medtronic - Mortara - Nihon Kohden - Omron - Philips Healthcare - Roche - Schiller - Spacelabs Healthcare - Welch Allyn For more information visit http://www.researchandmarkets.com/research/vz...nd_cardiac About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research Report - India Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6nzsc6/india) has announced the addition of the "India Orthobiologics Market Outlook to 2020" report to their offering. "India Orthobiologics Market Outlook to 2020", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the India Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, India Overview of Key Companies in India Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned DePuy Companies Sanofi Baxter International Inc. Medtronic, Inc. Orthofix International N.V. Biomet, Inc. Smith & Nephew Plc Wright Medical Group, Inc. Stryker Corporation For more information visit http://www.researchandmarkets.com/research/6nzsc6/india About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016
M2 - Wed Mar 12, 6:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4lq46f/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering. There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011. The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm. Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market. According to the report, one of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Vendor Landscape 8. Buying Criteria 9. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 15. Other Reports in this Series Companies Mentioned: - Advanced Cell Technology Inc. - Arteriocyte Inc. - Athersys Inc. - Baxter International Inc. - CryoLife - Cytori Therapeutics Inc. - Genzyme Corp. - Geron Corp. - InVivo Therapeutics - Inc. - Integra Life Sciences Holdings Corp. - Kensey Nash Corp. - Kinetic Concepts Inc. - Medtronic Inc. - NeoStem Inc. - Osiris Therapeutics Inc. - Osteotech Inc. - RTI Biologics Inc. - Stryker Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/4l...generative
Intravenous Access Devices Market Trends & Forecasts, 2019 - Needles, Catheters & Infusion Pumps
M2 - Tue Mar 11, 11:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/85klhj/intravenous) has announced the addition of the "Intravenous Access Devices Market Trends & Forecast, 2019 - Needles, Catheters & Infusion Pumps" report to their offering. This report studies the market for intravenous (IV) access devices utilized by physicians to deliver medication to the patients' bloodstream through the intravenous route and also to withdraw blood for testing purpose. The global intravenous access devices market is segmented into four categories in this report, namely, IV needles, IV catheters and IV infusion pumps. These product segments have been further classified based on the type of products. The intravenous catheters segment includes midline peripheral catheters and central catheters. Central catheters are further classified as peripherally inserted central catheters (PICC) and centrally inserted catheters. The intravenous infusion pumps segment includes insulin infusion pumps, parenteral feeding infusion pumps, patient controlled analgesia (PCA) infusion pumps and syringe infusion pumps. The report also includes a market overview section that discusses the drivers, restraints and opportunities in the market. In addition, it also provides Porter's five force analysis and market attractiveness analysis for the global intravenous access devices market. Market share in terms of percentage (for 2012) for major industry players has also been provided in the report along with a list of recommendations for new as well as existing players of the market. The report concludes with company profiles of the companies operating in this market, with details such as company overview, financial overview, product portfolio, business strategies and recent developments of each company. Some of the prominent players profiled in the report are Hospira, Inc., Becton, Dickinson & Company, CareFusion Corporation, Baxter International, Medtronic, Inc. and Covidien Plc. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Intravenous Access Devices Market, by Product Type Chapter 5 Global Intravenous Access Devices Market, by Geography Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles For more information visit http://www.researchandmarkets.com/research/85...ntravenous
Global Insulin Delivery Devices Market is Expected to Grow at a CAGR of 8.5% During 2012-2017
M2 - Tue Mar 11, 10:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rppmnp/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Forecast to 2017" report to their offering. 371 Million people had diabetes in 2012 and by 2030 this number is expected to rise to 552 Million. This finding by International Diabetes Federation (IDF) and similar results from studies done by organizations of repute like WHO, CDC, NHS etc. suggest that a huge patient population exists for the diabetes healthcare market. It is estimated that in 2011, around US$ 465 Billion were spent on healthcare expenditures related to diabetes. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In latest research study, Global Insulin Delivery Devices Market Forecast to 2017, the company's analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 8.8 Billion in 2012, is expected to grow at a CAGR of 8.5% during 2012-2017. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of delivery devices' market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth and its future outlook. This study leads to the proposition that innovation has huge scope in this field and its analysts have advertently elaborated some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, Becton, Dickinson and Company that together account for more than 90% of the global market. Companies Mentioned: - Novo Nordisk - Eli Lilly - Medtronic - Becton Dickinson - Sanofi-Aventis - F. Hoffmann La Roche For more information visit http://www.researchandmarkets.com/research/rp...al_insulin About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Watch for Shares of Medtronic (MDT) to Approach Resistance at $60.56
Comtex SmarTrend(R) - Tue Mar 11, 10:45AM CDT
Medtronic (NYSE:MDT) has opened bullishly above the pivot of $59.86 today and has reached the first level of resistance at $60.31. Analysts will be watching for a cross of the next upside pivot targets of $60.56 and $61.26.
Final Glance: Medical Devices companies
AP - Thu Mar 13, 5:05PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
Midday Glance: Medical Devices companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Early Glance: Medical Devices companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Pre-Market Health Care Stocks Analysis: Medtronic, Abbott Laboratories, Hologic, and ArthroCare
PR Newswire - Thu Mar 13, 7:00AM CDT
On Wednesday, March 12, 2014, the NASDAQ Composite ended at 4,323.33, up 0.37%, the Dow Jones Industrial Average fell 0.07% to 16,340.08, and the S&P 500 closed at 1,868.20, up 0.03%. The gains were narrow based as four out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 687.90, down 0.01%, while the same has gained 3.36% in the last one month. Investor-Edge.com has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Hologic Inc. (NASDAQ: HOLX), and ArthroCare Corporation (NASDAQ: ARTC). Free research on these four companies can be accessed at:
Concise Analysis of the International Intracranial Stents Market
M2 - Thu Mar 13, 6:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4fntp/intracranial) has announced the addition of the "Concise Analysis of the International Intracranial Stents Market" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. The report profiles 16 companies including many key and niche players such as: - Admedes Schuessler GmbH - BALT Extrusion - Cardiatis SA - Codman & Shurtleff, Inc. - Covidien PLC - ITGI Medical Ltd. - Medtronic, Inc. - MicroPort Scientific Corporation - OBEX Medical - Penumbra, Inc. - Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Issues & Challenges 3. Product Overview 4. Neurovascular Diseases - An Overview 5. Product Introductions & Approvals 6. Recent Industry Activity 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Europe 3. Rest Of World IV. Competitive Landscape Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18) - The United States (7) - Europe (6) - France (1) - Germany (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/r4...tracranial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
United States Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 5:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jjmsm9/united_states) has announced the addition of the "United States Orthobiologics Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Bone Graft Substitutes - Viscosupplementation - Bone Allografts - Bone Growth Stimulators The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. Scope - Market size for Orthobiologics market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the United States Orthobiologics market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution? Identify, understand and capitalize. Key Topics Covered - Introduction - Orthobiologics Market, United States - Overview of Key Companies in United States Orthobiologics Market - Orthobiologics Market Pipeline Products - Financial Deals Landscape - Recent Developments - Appendix Companies Mentioned - Anika Therapeutics - Baxter International - Biomet - DJO Finance - DePuy - Globus Medical - Medtronic - NuVasive - Sanofi - Seikagaku - Smith & Nephew - Stryker - Wright Medical For more information visit http://www.researchandmarkets.com/research/jj...ted_states About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
2014 Bone Grafts Global Strategic Business Report - Growing Clinical Use of Bone Graft Substitutes in Surgical Procedures
M2 - Thu Mar 13, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtgc4c/bone_grafts) has announced the addition of the "Bone Grafts - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Bone Grafts in US$ Million. The US market for Bone Graft Substitutes is also analyzed by the following segments: Standard Allografts, Machined Bone Allografts, Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Stem Cell Based Bone Grafts, and Synthetic Bone Grafts. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. MARKET DYNAMICS 3. PRODUCT OVERVIEW 4. REGULATORY ENVIRONMENT & REIMBURSEMENTS 5. PRODUCT INNOVATIONS/INTRODUCTIONS - AlloSource Introduces AlloMend - Orthofix Launches Trinity? ELITE - Synergy Biomedical to Introduce Biosphere Putty - K2M Launches VENADO Bone Graft Systems - Bonesupport Receives CE Mark Approval for Cerament|G resorbable - PlusLife? Launches Innovative Allogeneic Bone Gel for Orthopedic Uses (Australia) - RTI Surgical Introduces BioReady DBM Putty - K2M Rolls Out VESUVIUS Osteobiologic Systems - BioHorizons Introduces MinerOss? Cancellous - Amedica Introduces Dynamic Bone - Orthogen Introduces NanoGen - SIRAKOSS Introduces MaxSi - BioMimetic to Introduce Augmatrix Biocomposite Bone Graft Line - Orthofix International Introduces Collage Osteoconductive Scaffold - BioMimetic Obtains Approval from TGA for Commercialization of Augment? Bone Graft - Medtronic Launches ARTISAN Space Maintenance System - NovaBone Introduces MacroPor-Si - RTI Surgical Announces First Application of map3TM Cellular Allogeneic Bone Graft in Ankle and Foot Fusion Procedures ( US) - Integra Receives FDA Clearance for Accell Evo3 - RTI Surgical Introduces BioAdapt DBM Foam - Integra Unveils Trel-Xpress Demineralized Bone Matrix - Keystone Dental Introduces DynaMatrix Plus - Wright Introduces FUSIONFLEX Demineralized Moldable Scaffold - Micromedics Launches OsteoXpress 15cc Bone Graft Delivery Device - Bacterin Unveils OsteoSponge?SC - Integra Launches Allograft Cancellous Sponge - Orthos Receives CE Approval for ?Gel Synthetic Bone Graft Substitute 6. RECENT INDUSTRY ACTIVITY - RTI Biologics Acquires Pioneer Surgical Technology - Wright Medical Group Acquires BioMimetic Therapeutics - Titan Spine Enters into Distribution Agreement with Biomet - Bioventus and Pfizer Enter into Agreement - AlloSource Enters into Partnership with Humacyte - MicroPort Medical to Acquire OrthoRecon Business of Wright Medical Group - J&J Takes Over Synthes - Stryker Acquires Orthovita - Zimmer Dental and Curasan Enter into Distribution Agreement - Cayenne Medical Enters into Partnership with Parametrics Medical - NuVasive Signs Licensing Agreement with AlloSource - Stryker Divests OP-1 Product Range 7. FOCUS ON SELECT PLAYERS 8. MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. EUROPE 3. REST OF WORLD IV. COMPETITIVE LANDSCAPE Companies Mentioned The report profiles 61 companies including many key and niche players such as: - AlloSource - Biomet - DePuy Synthes - Synthes - DePuy Spine - Exactech - Integra LifeSciences - LifeNet Health - Medtronic - NovaBone Products - NuVasive, - Olympus Biotech - RTI Surgical - Smith & Nephew - Stryker - Wright Medical Technology - BioMimetic Therapeutics - Zimmer For more information visit http://www.researchandmarkets.com/research/dt...one_grafts About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Market Research: Mexico Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/klxv39/mexico) has announced the addition of the "Mexico Orthobiologics Market Outlook to 2020" report to their offering. "Mexico Orthobiologics Market Outlook to 2020", provides key market data on the Mexico Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Mexico Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, Mexico Overview of Key Companies in Mexico Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned Sanofi Medtronic, Inc. DePuy Companies Biomet, Inc. Orthofix International N.V. Stryker Corporation Arthrex, Inc. Wright Medical Group, Inc. DJO Finance LLC Ferring International Center S.A. Baxter International Inc. For more information visit http://www.researchandmarkets.com/research/klxv39/mexico About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019
M2 - Thu Mar 13, 3:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vzjflp/blood_and_cardiac) has announced the addition of the "Blood and Cardiac Monitoring Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2019" report to their offering. According to the report the global blood and cardiac monitoring devices market was worth $13.6 billion in 2012 and is expected to reach $20.5 billion in 2019, growing at a CAGR of 6.0% from 2013 to 2019. The market for blood monitoring devices is segmented into blood pressure monitors, blood glucose monitors, blood gas analyzers and blood cholesterol monitors. In 2012, the market for blood glucose monitors accounted for the largest share by revenue of the total market at more than 70%. This is attributed mainly to the consistent technological up-gradations in product design followed by the alarming rise in diabetic population and sedentary lifestyles. However, the blood pressure monitors market is expected to record the highest growth during the forecast period owing to the rising prevalence and incidence rate of hypertension and increased awareness about regular monitoring of blood pressure among people. Also, due to integration of tele-medicine, patients themselves rely on self-monitoring of blood pressure at home. The market for cardiac monitoring devices has been segmented into various device types including electrocardiogram, holter monitors, event monitors, cardiac output monitors, and others (wrist rate monitors, strapped rate monitors, etc.). Of these, the market for electrocardiograms accounted for the largest share by revenue in 2012, at around 45%. Geographically, the market has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America led the global market for both blood and cardiac monitoring devices in 2012, in terms of revenue share. With innovations in blood monitoring making the testing much less invasive for the geriatric population and other cardiac patients, revenue for the North American market is set to skyrocket. Physicians in the region are increasingly demanding to work with the newer, less invasive or noninvasive systems, which will help in rapid growth of the minimally and non-invasive blood and cardiac monitoring markets. The fastest growth in this market will be observed in the Asia-Pacific region during the forecast period. Sedentary lifestyles and the resultant rise in the prevalence of chronic illnesses, increase in the per capita income and healthcare expenditures, improvement in healthcare infrastructure and a large pool of geriatric population are the key factors fuelling market growth in the region. The market for cardiac monitors is highly oligopolistic in nature, with the top two players accounting for the majority of the market share in 2012. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics: Global Blood and Cardiac Monitoring Devices Market - Products Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Geography Market Size & Forecast - Global Blood and Cardiac Monitoring Devices Market - Key Players Analysis: Global Blood and Cardiac Monitoring Devices Market, 2012 (%) - Company Profiles Companies Mentioned - Dragerwerk AG & Co. - Edwards Lifesciences - GE Healthcare - ICU Medical - LiDCO - Medtronic - Mortara - Nihon Kohden - Omron - Philips Healthcare - Roche - Schiller - Spacelabs Healthcare - Welch Allyn For more information visit http://www.researchandmarkets.com/research/vz...nd_cardiac About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research Report - India Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6nzsc6/india) has announced the addition of the "India Orthobiologics Market Outlook to 2020" report to their offering. "India Orthobiologics Market Outlook to 2020", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the India Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, India Overview of Key Companies in India Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned DePuy Companies Sanofi Baxter International Inc. Medtronic, Inc. Orthofix International N.V. Biomet, Inc. Smith & Nephew Plc Wright Medical Group, Inc. Stryker Corporation For more information visit http://www.researchandmarkets.com/research/6nzsc6/india About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016
M2 - Wed Mar 12, 6:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4lq46f/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering. There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011. The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm. Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market. According to the report, one of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Vendor Landscape 8. Buying Criteria 9. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 15. Other Reports in this Series Companies Mentioned: - Advanced Cell Technology Inc. - Arteriocyte Inc. - Athersys Inc. - Baxter International Inc. - CryoLife - Cytori Therapeutics Inc. - Genzyme Corp. - Geron Corp. - InVivo Therapeutics - Inc. - Integra Life Sciences Holdings Corp. - Kensey Nash Corp. - Kinetic Concepts Inc. - Medtronic Inc. - NeoStem Inc. - Osiris Therapeutics Inc. - Osteotech Inc. - RTI Biologics Inc. - Stryker Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/4l...generative
Intravenous Access Devices Market Trends & Forecasts, 2019 - Needles, Catheters & Infusion Pumps
M2 - Tue Mar 11, 11:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/85klhj/intravenous) has announced the addition of the "Intravenous Access Devices Market Trends & Forecast, 2019 - Needles, Catheters & Infusion Pumps" report to their offering. This report studies the market for intravenous (IV) access devices utilized by physicians to deliver medication to the patients' bloodstream through the intravenous route and also to withdraw blood for testing purpose. The global intravenous access devices market is segmented into four categories in this report, namely, IV needles, IV catheters and IV infusion pumps. These product segments have been further classified based on the type of products. The intravenous catheters segment includes midline peripheral catheters and central catheters. Central catheters are further classified as peripherally inserted central catheters (PICC) and centrally inserted catheters. The intravenous infusion pumps segment includes insulin infusion pumps, parenteral feeding infusion pumps, patient controlled analgesia (PCA) infusion pumps and syringe infusion pumps. The report also includes a market overview section that discusses the drivers, restraints and opportunities in the market. In addition, it also provides Porter's five force analysis and market attractiveness analysis for the global intravenous access devices market. Market share in terms of percentage (for 2012) for major industry players has also been provided in the report along with a list of recommendations for new as well as existing players of the market. The report concludes with company profiles of the companies operating in this market, with details such as company overview, financial overview, product portfolio, business strategies and recent developments of each company. Some of the prominent players profiled in the report are Hospira, Inc., Becton, Dickinson & Company, CareFusion Corporation, Baxter International, Medtronic, Inc. and Covidien Plc. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Market Overview Chapter 4 Global Intravenous Access Devices Market, by Product Type Chapter 5 Global Intravenous Access Devices Market, by Geography Chapter 6 Competitive Landscape Chapter 7 Recommendations Chapter 8 Company Profiles For more information visit http://www.researchandmarkets.com/research/85...ntravenous
Global Insulin Delivery Devices Market is Expected to Grow at a CAGR of 8.5% During 2012-2017
M2 - Tue Mar 11, 10:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rppmnp/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Forecast to 2017" report to their offering. 371 Million people had diabetes in 2012 and by 2030 this number is expected to rise to 552 Million. This finding by International Diabetes Federation (IDF) and similar results from studies done by organizations of repute like WHO, CDC, NHS etc. suggest that a huge patient population exists for the diabetes healthcare market. It is estimated that in 2011, around US$ 465 Billion were spent on healthcare expenditures related to diabetes. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In latest research study, Global Insulin Delivery Devices Market Forecast to 2017, the company's analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 8.8 Billion in 2012, is expected to grow at a CAGR of 8.5% during 2012-2017. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of delivery devices' market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth and its future outlook. This study leads to the proposition that innovation has huge scope in this field and its analysts have advertently elaborated some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, Becton, Dickinson and Company that together account for more than 90% of the global market. Companies Mentioned: - Novo Nordisk - Eli Lilly - Medtronic - Becton Dickinson - Sanofi-Aventis - F. Hoffmann La Roche For more information visit http://www.researchandmarkets.com/research/rp...al_insulin About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Watch for Shares of Medtronic (MDT) to Approach Resistance at $60.56
Comtex SmarTrend(R) - Tue Mar 11, 10:45AM CDT
Medtronic (NYSE:MDT) has opened bullishly above the pivot of $59.86 today and has reached the first level of resistance at $60.31. Analysts will be watching for a cross of the next upside pivot targets of $60.56 and $61.26.
(0)
(0)Medtronic, Inc. (MDT) Stock Research Links
Scroll down for more posts ▼